Navigation Links
Colon in Medical Technology

Procter & Gamble Pharmaceuticals Launches Asacol(R) HD (mesalamine) Delayed-Release Tablets

... UC involves inflammation of the lining of the colon and rectum and is typically characterized by ... UC involves inflammation of the lining of the colon and rectum. It varies in clinical severity with ... remission. During a flare, in which the rectum or colon become inflamed, people experience symptoms such ...

Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer

... in Patients with 2nd or 3rd Line Metastatic colon Cancer NEW YORK, June 1 ... with capecitabine as a treatment for advanced colon cancer. Abstract #4081, entitled, "Randomized ... in patients with second- or third-line metastatic colon cancer," was presented yesterday in a poster ...

Keryx Biopharmaceuticals Reports Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer

... in Patients with 2nd or 3rd Line Metastatic colon Cancer NEW YORK, May 31 ... with capecitabine as a treatment for advanced colon cancer. Abstract #4081, entitled, "Randomized ... in patients with second- or third-line metastatic colon cancer," is being presented today in a poster ...

Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women

... announced results regarding its Onco type DX colon cancer test, from the landmark QUASAR validation ... predict individual recurrence risk in stage II colon cancer patients following surgery. The study, "A ... assay for prediction of recurrence in stage II colon cancer: Selection of the genes in 4 large studies ...

Discovery of Marker for Colon Stem Cells Could Shed Light on What Drives Tumor Growth

... an enzyme common to both normal and malignant colon stem cells that will assist scientists searching for a cure for colon cancer. (Logo: ... locate, and isolate normal and malignant colon stem cells, has been elusive. But the discovery ...

Immunomedics Announces Preclinical Therapy Results of SN-38 Immunoconjugate for Colorectal Cancer

... conjugate, selectively delivers SN-38 to human colon carcinoma in animal models as an effective new ... was evaluated in two animal models of human colon cancer. Labetuzumab is a non-internalizing ... cancers. In a lung metastatic model of colon carcinoma, therapy with labetuzumab-SN-38 ...

ASGE Urges Patients to Seek a Qualified Endoscopist Before Undergoing a Colonoscopy for Colorectal Cancer

... of colorectal cancer on the right side of the colon OAK BROOK, Ill., Dec. 16 ... lesions more often on the right side of the colon versus the left side. The study highlights the ... their physician allowing for a clear view of the colon to detect lesions. The American Society for ...

Quality Colonoscopy Exam Remains Best Strategy for Detection of Polyps and Cancers According to Experts From the American College of Gastroenterology

... study on colonoscopy's impact on reducing colon cancer deaths suggests a lower impact on ... available option for detection of precancerous colon polyps and the only test with the potential to ... reaching the cecum, an anatomical landmark in the colon that represents a thorough exam. "Beyond ...

Micromet Presents Data at the 23rd Annual Meeting of the International Society for Biological Therapy of Cancer on the Activity of Human Antibody Adecatumumab against KRAS-mutated Colon Cancer Cells

... The new preclinical data indicated that human colon cancer cells are efficiently eliminated in tested ... show limited or no efficacy in the treatment of colon cancer patients with a mutated KRAS oncogene in ... disease. "Given that more than 95 percent of colon cancer patients strongly express EpCAM on their ...

Video: Large, Multi-Center Trial Demonstrates Comparable Accuracy for Virtual Colonoscopy and Standard Colonoscopy

... and minimally invasive evaluation of the entire colon and rectum. The ACRIN trial, sponsored by the ... with a high degree of accuracy. Since most colon cancers develop from polyps, and screening to find and remove these polyps can prevent colon cancer, an opportunity exists to save lives with ...

Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum

... a Blood-Based Test to Detect colon Cancer REHOVOT, Israel and JERSEY CITY, New ... will utilize microRNAs to detect patients with colon cancer. "This study further validates our ... of one of our development programs to detect colon cancer via microRNAs identified in serum. I ...

August 2008 Mayo Clinic Women's HealthSource Highlights Avoiding Blood Pressure Increase at Menopause, Healthful Benefits of Dark Chocolate and Scheduling a Colorectal Exam

... Colorectal Exam More options are available for colon cancer screenings ROCHESTER, Minn. -- For many ... regularly. Many have never been screened. colon cancer occurs in the large intestine, the lower ... at high risk, regular screening can help prevent colon cancer or detect it early, when it can be most ...

iCAD Initiates Clinical Study of Its Virtual Colonoscopy CAD in Partnership with ACR Image Metrix

... announced it has initiated a clinical study for colon CAD, its virtual colonoscopy CAD product, in ... clinical study designed to assess the impact of colon CAD on the accuracy of interpreting ... The study will also assess the sensitivity of colon CAD for detecting polyps and will measure the ...

Orion Genomics Gains Exclusive Worldwide Rights to the IGF2 Gene for Colorectal Cancer Risk Testing Through Licensing Agreement With Johns Hopkins University

... to remove precancerous polyps and prevent future colon cancer. Two published studies involving more ... the way populations are screened for colon cancer," said Graham Colditz, MD, DrPH, Associate ... resources to the people most likely to develop colon cancer." "Colorectal cancer is the second most ...

Genomic Health Announces Results of Initial Studies to Develop Predictive Tests for Targeted Therapies

... Response to Targeted Therapies for colon and Breast Cancers - REDWOOD CITY, Calif., May ... ERBITUX (cetuximab), a targeted therapy for colon cancer. Researchers analyzed formalin-fixed, paraffin-embedded tumor samples from 226 colon cancer patients from three studies of ERBITUX. ...

New Eloxatin(R) (oxaliplatin injection) Prescribing Information in the U.S. Includes Six-Year Overall Survival Data

... Survival at Five Years, For Stage III colon Cancer, Post Surgery - BRIDGEWATER, N.J., May ... free survival (DFS) data in Stage III colon cancer patients treated following surgery to ... after a median follow-up of six years, Stage III colon cancer patients treated with FOLFOX4 had a ...

Karmanos Researchers Find Non-Toxic Agents Added to Conventional Chemotherapy Decrease Survival of Colon Cancer Cells

... in preventing the growth of chemo-resistant colon cancer cells. The poster presentation was ... (FOLFOX) would decrease the survival of colon cancer cells. Studies confirmed that both are effective and inhibit the growth of new colon cancer cells, with curcumin appearing to be ...

Inclusion of Six-Year Overall Survival Data in the Eloxatin(R) (oxaliplatin injection) Prescribing Information Granted FDA Priority Review

... Improved Six-year Overall Survival in Stage III colon Cancer Following Surgery Compared to ... five-year disease free survival data in Stage III colon cancer patients treated with either FOLFOX4 ... chemotherapy regimen for their Stage III colon cancer patients." In the MOSAIC trial, Stage ...

Oxygen Relieves IBS and Constipation Symptoms in New Clinical Studies

... clinical studies indicating their oxygen colon cleanser is extremely successful at relieving ... LAXATIVES ... with a zero-percent failure rate. colon cleansing with an oxygen colon cleanser is likely to become the new standard for ...

Genomic Health Announces Identification of Genes Associated With Colon Cancer Recurrence Across Multiple Studies

... Final Genes for colon Cancer Test - REDWOOD CITY, Calif., Jan. 28 ... benefit for early-stage (stage II and III) colon cancer. The company is conducting detailed ... identify genes that may predict the likelihood of colon cancer recurrence and chemotherapy benefit," said ...

Over 30 New Studies of Oral Xeloda(R) Featured at the 2008 Gastrointestinal Cancers Symposium

... against those of 5-FU-based regimens in colon and rectal cancer. The fifth U.S. abstract ... in the treatment of patients with colon or rectal cancer (CRC) (Presenter: Edward Chu) ... No. 465], Capecitabine use in patients with colon and rectal cancer (CRC): A claims database ...

iCAD Announces Partnership for Initiating Clinical Testing of Its Virtual Colonoscopy CAD Product

... a multi-reader clinical study of iCAD's CT colon product, for use with Virtual Colonoscopy. With ... Food and Drug Administration (FDA) approval of CT colon CAD. ACR Image Metrix was launched by the ... a major step forward in the development of our colon CAD product," said Ken Ferry, President and Chief ...

American Meat Institute Calls WCRF Panel Recommendations on Meat Consumption Extreme and Unfounded

... Data Showing No Relationship Between Meat and colon Cancer Not Considered Huffman expressed strong ... that the largest study ever done on red meat and colon cancer -- a 2004 Harvard School of Public Health ... meat and processed meat were not associated with colon cancer." Media reports indicate that lawmakers ...

Viatronix V3D-Colon Utilized in 'Another' Landmark Study

... effective, and cost-effective technique for colon cancer screening About Viatronix Viatronix is a ... allows physicians to interactively view the colon reconstructed from a CT scan, providing visualization of the entire colon wall which includes polyps and other lesions. The ...

Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting

... data from the X-ACT (Xeloda in Adjuvant colon Cancer Trial) study show that oral chemotherapy ... - in the adjuvant treatment of Dukes' C colon cancer. These data were presented today at the ... Affairs, Roche. "Roche is committed to providing colon cancer patients with the safest and most ...

Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection

... It is a serious illness caused by infection of the inner lining of the colon by C. difficile bacteria, which produce toxins that cause inflammation ... may facilitate the return of the normal physiological conditions in the colon and reduce the probability of CDI recurrence. About Optimer ...

Cequent tkRNAi Technology to be Presented at the Centennial Meeting of the American Association for Cancer Research

... Data presented here targets oncogenes relevant for colon cancer, but this tkRNAi technology may also prove ... the colon, people with FAP almost inevitably develop colon cancer, and there is no medical treatment available. ...

Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference

... removal of the colon, people with FAP almost inevitably develop colon cancer, and there is no medical treatment available. Cequent will present ... shown previously in cell-culture assays and in a mouse model for human colon cancer that our tk RNAi technology effectively suppresses beta-catenin, a ...

National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon

... These results are important to doctors and patients because most cases of colon cancer arise from adenomas." Colorectal cancer is the second greatest ... lesions may be missed, especially if they are located behind folds in the colon wall and behind flexures, or tight turns in the colon," said Scott Dodson, ...

New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study

... That includes 2 patients receiving azathioprine monotherapy who developed colon cancer, one patient receiving azathioprine monotherapy who died following ... disease. Crohn's disease is a chronic inflammatory disease of the colon and large intestine that affects approximately 500,000 people in the ...

Immigrants From India, Pakistan Face U.S. Prostate, Breast Cancer Risks

... population in the United States also experiences rising rates of lung and colon cancer, again mirroring U.S. patterns. Immigrants have been shown to ... can take to reduce their risk of prostate, breast cancer, lung cancer and colon cancer," Dr. Abraham said. Immigrants from India and Pakistan make up ...

Pressure Cycling Technology (PCT) Results in a Higher Yield of Proteins and in the Extraction of Proteins Not Previously Identified in Cancer, Stroke, and IVF Studies

... results yesterday on advances they made in the areas of breast and colon cancer, stroke, and in vitro fertilization ("IVF"). The results were ... in the development of new therapeutics and diagnostics for breast and colon cancer and stroke, and may not result in more live births from single ...

Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City

... described the use of PCT in the extraction of proteins from breast and colon cancer tissue samples, as well as from the nutrient media used with ... in the development of new therapeutics and diagnostics for breast and colon cancer, IVF, stroke, or other procedures and diseases; that due to ...

Safety and Efficacy Results Presented From Largest Prospective Controlled Clinical Study of Ulcerative Colitis

... Ulcerative Colitis (UC) UC involves inflammation of the lining of the colon and rectum. It varies in clinical severity with patients having mild, ... followed by periods of remission. During a flare, in which the rectum or colon become inflamed, people experience symptoms such as diarrhea, rectal ...

Annual FIT Testing Detects Colorectal Cancer Two Years Earlier Than Colonoscopy Alone, Study of High-Risk Population Finds

... but when found early and treated, the five-year relative survival rate for colon cancer is 90 percent.(2) Currently, less than 40 percent of colorectal ... When found early and treated, the five-year relative survival rate for colon cancer is 90 percent(6), yet less than 40 percent of colorectal cancers ...

New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease

... subgroup. Ulcerative colitis is a chronic inflammatory disease of the colon and large intestine that affects approximately half a million Americans ... they bleed and produce pus and mucus. Because the inflammation makes the colon empty frequently, symptoms often lead to unwanted weight loss, blood loss ...

Cequent Pharmaceuticals' Johannes Fruehauf, MD, Ph.D., to be Featured Speaker at RNAi World Congress in Boston - May 2, 2008

... is to prevent polyp formation in patients with a high risk of developing colon cancer. In his talk, Dr. Fruehauf will give an overview of the ... trials. In April, Dr. Fruehauf presented mouse data from Cequent's colon cancer prevention program at the American Association for Cancer Research ...

Preclinical Study Shows CTI's Brostallicin's Cancer-Killing Ability Based on Genetic Profiling

... that the Company's experimental drug candidate, brostallicin, killed colon and ovarian cancer cells regardless of their p53 status. The study, ... safe and effective for treatment of solid tumors particularly ovarian or colon cancers, determinations by regulatory, patent and administrative ...

ACR Supports American Cancer Society Inclusion of CT Colonography (Virtual Colonoscopy) as Recommended Screening Tool for Colorectal Cancer in New Screening Guidelines

... including driving, immediately after the procedure. Since most colon cancers develop from polyps, and screening to find and remove these polyps can prevent colon cancer, an enormous opportunity exists to save lives with early detection. ...

Study Data Show Asacol(R) (Mesalamine) is Effective in Treating All Extents of Ulcerative Colitis Including Isolated Proctitis

... Ulcerative Colitis (UC) UC involves inflammation of the lining of the colon and rectum. It varies in clinical severity with patients having mild, ... followed by periods of remission. During a flare, in which the rectum or colon become inflamed, people experience symptoms such as diarrhea, rectal ...
Other Contents
(Date:3/20/2015)... , Mar. 20, 2015 Research and Markets ... addition of the "India Sensors Market Forecast ... The sensor market is projected to ... Consumer electronics, automotive, industrial and healthcare ... in the country. In addition, adoption of MEMS ...
(Date:3/19/2015)... Conn. , March 19, 2015  NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce market, announces ... in a news clip that aired this week on ... ) . In a segment "The Next Great ... wallet ,a new way to pay, and ,a really big ...
(Date:3/17/2015)...  MecklerMedia Corporation (OTCQX: MECK) announced its ... ever held in New York City ... 2015 at the Javits Convention Center. ... Acorn Product Development; Axis NJ; c-Link Systems; CoroWare; ... NewBotic Corporation; Neya Systems LLC; Reliabotics; RoboKind; RocketFarm ...
Breaking Biology News(10 mins):India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 3NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2
(Date:3/27/2015)... 2015 Bleeding is one of ... coronary intervention (PCI), resulting in increased mortality, morbidity, ... paradox,” in which the highest-risk PCI patients with ... less often with bleeding avoidance strategies than lower-risk ... America Heart Institute asked the question whether prospectively ...
(Date:3/27/2015)... CA (PRWEB) March 27, 2015 Healthpointe ... Stanley G. Katz, M.D., is now treating knee and ... including Anaheim , Long Beach, and La Mirada. ... of acute knee and hip joint disorders as well ... Katz is passionate in returning his patients back to ...
(Date:3/27/2015)... Ticket Down is a reputable source for authentic tickets ... a phenomenal and highly successful live tour last year, the cast ... tour again in 2015 and they will be visiting 8 cities ... in New York City at the cozy Beacon Theatre and will ... 10th. , Fans of the hit show can look forward to ...
(Date:3/27/2015)... While deep learning was the topic of many ... , the CEO of one start-up spoke passionately about using ... well beyond the generally-agreed ceiling of 120 years. , Insilico ... of 12 companies recognized as the hottest GPU-powered startups in ... GTC Emerging Companies Summit have business models focused on ...
(Date:3/27/2015)... 2015 According to a recently published ... plate and screw market in Europe is in decline ... and screw segment. Price decreases are being seen across ... 50% of the total European trauma device market, continued ... market value, year after year. , “Such price ...
Breaking Medicine News(10 mins):Health News:Precision Medicine Improves Use of Bleeding Avoidance Strategies and Reduces Bleeding in Patients Undergoing Percutaneous Coronary Intervention 2Health News:Precision Medicine Improves Use of Bleeding Avoidance Strategies and Reduces Bleeding in Patients Undergoing Percutaneous Coronary Intervention 3Health News:Fellowship-Trained and Board-Certified Orthopedic Surgeon is Now Treating Knee and Hip Joint Disorders in Anaheim, California 2Health News:Fellowship-Trained and Board-Certified Orthopedic Surgeon is Now Treating Knee and Hip Joint Disorders in Anaheim, California 3Health News:Nashville Live in Concert Tickets in New York, Boston, Washington, DC, Chicago, Minneapolis, San Francisco, Los Angeles and Phoenix Now On Sale at TicketDown.com 2Health News:InSilico Medicine, Inc. Stands Out from High Tech Startups at 2015 GPU Conference 2Health News:InSilico Medicine, Inc. Stands Out from High Tech Startups at 2015 GPU Conference 3Health News:Titanium Trauma Treatment Devices in Europe Becoming More Affordable, Decreasing Market Value: Group Purchasing Further Eroding Selling Prices 2Health News:Titanium Trauma Treatment Devices in Europe Becoming More Affordable, Decreasing Market Value: Group Purchasing Further Eroding Selling Prices 3
Other TagsOther Tags